featured
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM
Circulation 2024 Nov 18;[EPub Ahead of Print], MY Desai, K Wolski, A Owens, JB Geske, S Saberi, A Wang, M Sherrid, PC Cremer, NK Lakdawala, A Tower-Rader, D Fermin, SS Naidu, NG Smedira, H Schaff, Z Gong, L Mudarris, K Lampl, AJ Sehnert, SE NissenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.